Cargando…
Commentary: SARS-CoV-2 vaccines and cancer patients
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831848/ https://www.ncbi.nlm.nih.gov/pubmed/33450404 http://dx.doi.org/10.1016/j.annonc.2020.12.019 |
| _version_ | 1783641706569138176 |
|---|---|
| author | Corti, C. Curigliano, G. |
| author_facet | Corti, C. Curigliano, G. |
| author_sort | Corti, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7831848 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78318482021-01-26 Commentary: SARS-CoV-2 vaccines and cancer patients Corti, C. Curigliano, G. Ann Oncol Letter to the Editor European Society for Medical Oncology. Published by Elsevier Ltd. 2021-04 2021-01-12 /pmc/articles/PMC7831848/ /pubmed/33450404 http://dx.doi.org/10.1016/j.annonc.2020.12.019 Text en © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Corti, C. Curigliano, G. Commentary: SARS-CoV-2 vaccines and cancer patients |
| title | Commentary: SARS-CoV-2 vaccines and cancer patients |
| title_full | Commentary: SARS-CoV-2 vaccines and cancer patients |
| title_fullStr | Commentary: SARS-CoV-2 vaccines and cancer patients |
| title_full_unstemmed | Commentary: SARS-CoV-2 vaccines and cancer patients |
| title_short | Commentary: SARS-CoV-2 vaccines and cancer patients |
| title_sort | commentary: sars-cov-2 vaccines and cancer patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831848/ https://www.ncbi.nlm.nih.gov/pubmed/33450404 http://dx.doi.org/10.1016/j.annonc.2020.12.019 |
| work_keys_str_mv | AT cortic commentarysarscov2vaccinesandcancerpatients AT curiglianog commentarysarscov2vaccinesandcancerpatients |